Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study

Arthritis Care Res (Hoboken). 2012 Jan;64(1):122-31. doi: 10.1002/acr.20589.

Abstract

Objective: To determine the frequency of incident vertebral fractures (IVF) 12 months after glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at higher risk.

Methods: Children with rheumatic diseases initiating GC were enrolled in a prospective observational study. Annual spine radiographs were evaluated using the Genant semiquantitative method. Spine areal bone mineral density (aBMD) was measured every 6 months. Clinical features, including cumulative GC dose, back pain, disease and physical activity, calcium and vitamin D intake, and spine aBMD Z scores, were analyzed for association with IVF.

Results: Seven (6%) of 118 children (95% confidence interval 2.9-11.7%) had IVF. Their diagnoses were: juvenile dermatomyositis (n = 2), systemic lupus erythematosus (n = 3), systemic vasculitis (n = 1), and mixed connective tissue disease (n = 1). One child was omitted from the analyses after 4 months because of osteoporosis treatment for symptomatic IVF. Children with IVF received on average 50% more GC than those without (P = 0.030), had a greater increase in body mass index (BMI) at 6 months (P = 0.010), and had greater decrements in spine aBMD Z scores in the first 6 months (P = 0.048). Four (67%) of 6 children with IVF and data to 12 months had spine aBMD Z scores less than -2.0 at 12 months compared to 16% of children without IVF (P = 0.011).

Conclusion: The incidence of VF 12 months following GC initiation was 6%; most children were asymptomatic. Children with IVF received more GC, had greater increases in BMI, and had greater declines in spine aBMD Z scores in the first 6 months.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorptiometry, Photon
  • Adolescent
  • Back Pain / chemically induced
  • Back Pain / epidemiology
  • Body Mass Index
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / therapeutic use
  • Canada / epidemiology
  • Child
  • Child, Preschool
  • Diphosphonates / therapeutic use
  • Dose-Response Relationship, Drug
  • Female
  • Glucocorticoids / adverse effects*
  • Humans
  • Incidence
  • Lumbar Vertebrae / diagnostic imaging
  • Lumbar Vertebrae / drug effects*
  • Male
  • Prospective Studies
  • Rheumatic Diseases / drug therapy*
  • Rheumatic Diseases / epidemiology
  • Risk Assessment
  • Risk Factors
  • Spinal Fractures / chemically induced*
  • Spinal Fractures / diagnostic imaging
  • Spinal Fractures / drug therapy
  • Spinal Fractures / epidemiology
  • Time Factors

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Glucocorticoids

Grants and funding